POUCO CONHECIDO FATOS SOBRE FDA APPROVED OBSTRUCTIVE SLEEP APNEA TREATMENT.

Data indicate that the Inspire device reduces sleep apnea by an average of 79% and significantly reduces snoring and daytime sleepiness. In addition to daytime tiredness and irritability, people with sleep apnea are at higher risk for stroke, type 2 diabetes, metabolic syndrome and liver problems.Data from the Inspire clinical trial showed that 85%